Clinical trials
Kidney Diseases trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Medical Center Groningen | 4 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Leiden University Medical Center | 2 |
| Radboud University Medical Center | 2 |
| Takeda | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Alnylam Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 36 |
| Diabetic Nephropathies | 6 |
| Renal Insufficiency, Chronic | 5 |
| Urologic Diseases | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Genetic Diseases, Inborn | 3 |
| Hyperoxaluria, Primary | 3 |
| Hypertension | 3 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.